HR 4881
118th Congress
House
Health
Congressional oversight
Government studies and investigations
Health care costs and insurance
Medicare
Prescription drugs
To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program.
Introduced: July 25, 2023
Introduced by:
Malliotakis, Nicole
Republican
· New York
See on congress.gov
Everywhere this bill has been
9 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
Dec 6, 2023
Ordered to be Reported (Amended) by the Yeas and Nays: 45 - 0.
Dec 6, 2023
Committee Consideration and Mark-up Session Held
Dec 5, 2023
Committee Consideration and Mark-up Session Held
Nov 15, 2023
Forwarded by Subcommittee to Full Committee by Voice Vote.
Nov 15, 2023
Subcommittee Consideration and Mark-up Session Held
Jul 28, 2023
Referred to the Subcommittee on Health.
Jul 25, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 25, 2023
Introduced in House
Plain-English summary
This bill limits cost-sharing for covered drugs under the Medicare prescription drug benefit and Medicare Advantage.
Specifically, for costs above the deductible but below the annual out-of-pocket threshold, the bill limits cost-sharing to the average net price of the drug (i.e., the average amount paid less any rebates) or the cash price (i.e., the price charged to an individual without insurance), whichever is lower.
The Government Accountability Office must report on the bill's implementation.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
4